In this study, A1R and A2AR agonists were found to aggravate liver fibrosis in CCl4-induced mouse models, characterized by increased serum ALT and AST levels, increased pathological damage, and collagen deposition in liver tissues. Here, ADORA2A is linked to Hepatic fibrosis.